Antonio Scardino

H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies

Hüseyin Firat, Francisco Garcia‐Pons, Sophie Tourdot et al. · European Journal of Immunology · 1999 · 176 citations · Full text

Histocompatibility, H-2 Class, Hla Immunogenetics +19

A general strategy to enhance immunogenicity of low-affinity HLA-A2.1-associated peptides: implication in the identification of cryptic tumor epitopes

Sophie Tourdot, Antonio Scardino, Eleanna Saloustrou et al. · European Journal of Immunology · 2000 · 125 citations

Hla, Histocompatibility, General Strategy +20

HER-2/ <i>neu</i> and hTERT Cryptic Epitopes as Novel Targets for Broad Spectrum Tumor Immunotherapy

Antonio Scardino, David‐Alexandre Gross, Pedro M. Sousa Alves et al. · The Journal of Immunology · 2002 · 121 citations · Full text

ALK as a novel lymphoma-associated tumor antigen: identification of 2 HLA-A2.1–restricted CD8+ T-cell epitopes

Lorena Passoni, Antonio Scardino, C Bertazzoli et al. · Blood · 2002 · 96 citations · Full text

Generation of CTL Recognizing an HLA-A*0201-Restricted Epitope Shared by MAGE-A1, -A2, -A3, -A4, -A6, -A10, and -A12 Tumor Antigens: Implication in a Broad-Spectrum Tumor Immunotherapy

Stéphanie Graff‐Dubois, Olivier Faure, David‐Alexandre Gross et al. · The Journal of Immunology · 2002 · 74 citations · Full text